Lenograstim - CISMeF

Preferred Label : Lenograstim;

MeSH definition : A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain.;

MeSH Related Number : 130120-54-6 (Component 2); 130120-55-7 (Component 1);

UNII : 6WS4C399GB;

Details

Origin ID

D000078224;

UMLS CUI

C0218640;

ATC code(s)
- lenograstim [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lenograstim [ICD-11 Extension code]
- colony stimulating factor 3 [HGNC gene]
CISMeF manual mappings
- Lenograstim adverse reaction (disorder) [SNOMED CT concept]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
- hematologic agents [MeSH Descriptor]
Record concept(s)
- euprotin [MeSH concept]
- granocyte [MeSH concept]
- lenograstim [MeSH concept]
- lenograstim, component 1 [MeSH concept]
- lenograstim, component 2 [MeSH concept]
See also inter- (CISMeF)
- Product containing lenograstim (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- lenograstim [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients